RE:RE:MIBCWhatever man . 60 Days is almost up for fast track and that legitimizes our compound as more than snake oil so that roswell can justify swapping photofrin for tld 1433 that simple.. and we gain overnight access to a nsclc phase 1 trial which we wont pay for and a market over 10b
Hempdoc wrote: Enrique wrote:
"IMO We just need to pass the proper threshold where we provide enough proof of safety and efficacy where it becomes obvious to ALL."
Yep, & Roswell Park should certainly ice the cake if all goes well, proving TLD-1433 safety/efficacy across multiple indications. Then it snowballs from their in terms of funding/grants, additional indications, expedited/accelerated approvals in other indications, & "additional & more frequent" off-label use (post approval for BCG-unresponsive NMIBC).
Here are some off-label uses that are "currently" being utilized...high-grade esophageal dysplasia/precancerous esophageal lesions, early esophageal cancer, non-endobronchial NSCLC, mesothelioma, gynecological dysplasia/cancers, skin cancers, intra-peritoneal cancers, colon/rectal cancers & certain head/neck cancers, including oral cancers.
We just need to wait a little longer (though LS may dispute timing ;) to put our TLD-1433 stamp on ALL of the above : )